add

Balanced Portfolio

High Conviction – Add Telix Pharmaceuticals

As of August 5, 2025 (mid-morning AEST), Telix Pharmaceuticals (TLX) is trading around A$16.84–16.75, down approximately 17% from its previous close of A$20.24. This sharp intraday decline aligns closely with your noted price of $17 (assuming AUD). Below, I’ll address the reasons for this correction based on recent developments and why it still represents a strong buying opportunity to add to positions.

Balanced Portfolio

Balanced Portfolio Recommendation: Buy – Arcadium Lithium Plc (LTM)

Incorporating a 3% allocation to Arcadium Lithium (LTM) within our balanced portfolio represents a prudent investment strategy, given the stock’s attractive valuation relative to its sector peers. This investment opportunity is underscored by LTM’s competitive market positioning and the current undervaluation, suggesting a favorable entry point. Additionally, the stabilization of lithium prices, alongside emerging signs of recovery in the commodity market, indicates a positive outlook for lithium demand. This is particularly relevant in light of the growing electric vehicle and renewable energy markets.

Balanced Portfolio

Balanced Portfolio Recommendation: Buy Add – IPD Group (IPG)

Buy Add – IPD Group Limited, based in Australia, specializes in distributing electrical equipment, offering various solutions under well-known brands like ABB, Elsteel, Emerson, and Red Lion. They provide services such as installation, calibration, maintenance, and more. Serving a diverse customer base including switchboard manufacturers, wholesalers, contractors, and utilities, the company has a long history since its founding in 1889 and was previously known as Alstom Industrial Products Limited before changing its name in 2006.

Scroll to Top